We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
As it turns out, the stock market loved today’s Fed announcement about a 25 bps rate cut. The small-cap Russell 2000 zoomed to a new all-time-high close, while the S&P 500 came within 5 points of its own all-time high. Bond yields, which had ratcheted up to +4.2% on the 10-year, were back down again by the press conference following the Fed statement. There’s now a 60 basis-point (bps) spread between 2-year and 10-year bond yields, for the first time in recent memory.
The Dow climbed +497 points on the day, +1.05%, while the S&P was +46, +0.67%. The Nasdaq was the laggard, only up 77 points or +0.33%, and the Russell gained +33 points, +1.32%. Markets closed off their session highs, ultimately, but there is no question this mini-rally was spurred following the Fed release. Year to date, markets are up +12% (Dow) to +22.5% (Nasdaq).
Notes on Today’s FOMC Meeting
For a Fed meeting that was well telegraphed and reported-on in advance, today’s announcement following the latest Federal Open Market Committee (FOMC) meeting did provide some surprises. We did see a -25 basis-point (bps) cut to the Fed funds rate to a range of 3.50-3.75%, but we saw three dissents from the official policy decision for the first time in six years: Chicago Fed President Goolsbee and Kansas City Fed President Schmid voted for no cut this time around, whereas Fed Governor Stephen Miran — on loan from the Trump White House — voted again for a 50 bps cut.
The other, seemingly bigger, surprise is that the augmentation to the Fed balance sheet has now come sooner and at a higher rate than expected. Starting in two days, the Fed will be purchasing $40 billion in Treasury bills, maintaining its balance sheet with an “ample level of reserves.” This “QE adjacent” move was earlier expected to net $20-30 billion in assets beginning some time after the start of the year, so it is a dovish move within what’s being called a hawkish cut.
The Fed’s outlook for 2026 Gross Domestic Product (GDP) moves up half a percentage point to +2.4% currently, with the Inflation Rate predicted to tick down 10 bps to +2.5%, and +2.1% for 2027. As such, 11 Fed members now advocate one rate cut or fewer for all of next year, with seven members in favor of no cuts at all. The conspicuous Miran, on the other hand, advocated a +2.12% Fed funds rate a year from now — 125 basis points in cuts in 2026.
In his press conference, Powell suggested that the current Fed funds rate is within range of the overall neutral rate of inflation. From the top interest rate levels back in September of 2024, the Fed has reduced by -175 bps. Powell referred to the Fed being “well positioned” several times in terms of its preparation to deal with current economic conditions going forward. In all, it was a dovish message from what was largely expected to be a hawkish cut this afternoon.
Earnings Results After the Close: ORCL, ADBE, SNPS
OracleORCL posted fiscal Q2 earnings results after today’s closing bell with mixed results: earnings of $2.26 per share was a big beat over the $1.63 in the Zacks consensus, while revenues of $16.1 billion were a bit shy of the $16.15 billion analysts were looking for. Remaining Performance Obligations (RPO), which had been a big positive surprise a quarter ago, continued to outperform expectations.
This RPO business, while providing lower margins for the company than other products and services, is nevertheless a gangbusters business these days. Taking in AI and cloud overruns for companies like Meta and NVIDIA rose +438% year over year, even higher than the Q3 tallies. Yet Oracle shares are trading down -3.8% in the after-market, ahead of the company’s conference call.
Adobe SystemsADBE benefited from strong adoption of its AI tools in its fiscal Q4, and resulted in solid beats on both top and bottom lines this afternoon. Earnings of $5.50 per share outpaced expectations of $5.39 (and well above the $4.81 per share reported a year ago) on $6.19 billion in revenues, bettering the $6.10 billion in the Zacks consensus estimate. Guidance for its Q1 was also raised. Shares are up +1% in late trading.
SynopsysSNPS also outpaced expectations in its fiscal Q4 results after today’s close, with earnings of $2.90 per share on $2.26 billion in revenues improving on estimates for $2.79 per share and $2.25 billion, respectively. The company announced a $11.4 billion in backlog, and a big upward adjustment to next-quarter revenues are helping shares gain +5.5% in after-hours trading. Questions or comments about this article and/or author" Click here>>
We cover more than 1,000 of the most widely followed stocks in our Equity Research Reports. Each report features independent research from our analysts and provides in-depth analysis on a company, its fundamentals and its growth prospects. Quickly access reports for New Upgrades and New Downgrades.
You can also find a report on the ticker of your choice, or access all of the stock reports covered by Zacks analysts.
Rise in demand for cybersecurity-related products due to continuously increasing global hacking events, along with acquisitions, is likely to drive Gen Digital’s near-term results.
Broad range of product and service offerings, ADAS technology development, new business wins, solid liquidity profile and investor friendly moves augur well for Magna's prospects.
Aptiv is well poised to gain from technology investments and acquisitions that help it capitalize on developing opportunities in the automotive market.
The company’s rising premiums on the back of solid segmental contributions impresses. Accelerated capital deployment and strategic acquisitions should boost investor confidence.
Science Applications International (SAIC)Upgraded: 12/06/25
Higher spending as proposed in the latest federal government budget is anticipated to accelerate the pace of contract awards which in turn will be beneficial for Science Applications’ top-line growth.
North America continues to be the key driver of Zumiez’s performance and profitability. In the third quarter, the region generated $202.8 million in sales, up 8.6% from the prior year.
Systematic capital investments to strengthen infrastructure, dividend hikes and the expanding natural gas customer base are going to drive its performance.
Cardinal Health is driving growth through specialty pharma, at-home care, and GMPD turnaround, supported by strategic acquisitions that expand margins and diversify beyond low-margin distribution.
The Hain Celestial Group (HAIN)Downgraded: 12/06/25
Hain Celestial’s North America segment is critical for overall company growth and consistent underperformances in major categories could drag down future performance.
Higher feedstock costs are expected to hurt the company's margins. Weaker selling prices and softer demand may also affect its performance. High debt is another concern.
Newell’s third-quarter 2025 top-line results were hurt by lower core sales, as well as the impacts of a challenging macroeconomic backdrop. Sales fell 7.2% year over year in the quarter.
American Eagle remains well placed on the back of cost-reduction efforts and brand progress. In addition, its Powering Profitable Growth plan bodes well.
Innovative Medicine unit is showing a growth trend, driven by existing products like Darzalex, Tremfya and Erleada and continued uptake of new launches, including Spravato, Carvykti and Tecvayli.
Broadcom is a leading player in the semiconductor market based on its expanding product portfolio, multiple target markets, accretive acquisitions and strong cash flow.
Decent loan demand and expansion into new markets by opening financial centers are expected to support Bank of America. Also, digital enhancement will likely keep aiding cross-selling opportunities.
Strength in the Energy Generation/Storage business, balance sheet strength, and focus on autonomous driving and artificial intelligence are set to drive Tesla.
Strength across all product groups is a positive catalyst for Edwards Lifesciences. The company’s bullish long-term growth strategy buoys optimism on the stock.
Align Technology’s robust product line, balanced growth across all channels and consistent focus on international markets to drive growth bolster our confidence in the stock.